Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Net Cash Flow (2019 - 2025)

Burning Rock Biotech has reported Net Cash Flow over the past 7 years, most recently at $3.2 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 29.84% year-over-year to $3.2 million; the TTM value through Dec 2025 reached -$7.6 million, up 75.77%, while the annual FY2025 figure was -$4.4 million, 67.14% up from the prior year.
  • Net Cash Flow for Q4 2025 was $3.2 million at Burning Rock Biotech, up from $1.9 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $26.4 million in Q1 2021 and troughed at -$40.9 million in Q3 2023.
  • A 5-year average of -$13.7 million and a median of -$14.1 million in 2024 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: tumbled 225.21% in 2021 and later soared 196.85% in 2024.
  • Year by year, Net Cash Flow stood at -$29.2 million in 2021, then rose by 22.08% to -$22.8 million in 2022, then surged by 88.7% to -$2.6 million in 2023, then soared by 196.85% to $2.5 million in 2024, then increased by 29.84% to $3.2 million in 2025.
  • Business Quant data shows Net Cash Flow for BNR at $3.2 million in Q4 2025, $1.9 million in Q3 2025, and -$9.3 million in Q2 2025.